Scholtz & Company, LLC Becton Dickinson & CO Transaction History

Scholtz & Company, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$236.45 - $266.82 $272,863 - $307,910	-1,154 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$230.58 - $256.08 $95,229 - $105,761	-413 Reduced 26.36%	1,154 $292,000
Q2 2019 Aug 14, 2019	BUY	$217.4 - $246.08 $117,613 - $133,129	541 Added 52.73%	1,567 $395,000
Q1 2019 May 15, 2019	SELL	$206.05 - $248.17 $101,994 - $122,844	-495 Reduced 32.54%	1,026 $256,000
Q4 2018 Jan 29, 2019	SELL	$204.73 - $257.93 $751,768 - $947,118	-3,672 Reduced 70.71%	1,521 $343,000
Q3 2018 Nov 14, 2018	SELL	$233.07 - $256.0 $34,727 - $38,144	-149 Reduced 2.79%	5,193 $1.36 Million
Q2 2018 Aug 13, 2018	SELL	$208.1 - $233.85 $1.5 Million - $1.68 Million	-7,193 Reduced 57.38%	5,342 $1.28 Million
Q1 2018 May 11, 2018	BUY	$205.46 - $240.27 $2.38 Million - $2.79 Million	11,598 Added 1237.78%	12,535 $2.72 Million
Q4 2017 Feb 14, 2018	BUY	$189.0 - $222.64 $177,093 - $208,613	937	937 $201,000

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.3B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Scholtz & Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Scholtz & Company, LLC with notifications on news.